TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biovica International AB
Closing information (x1000 NOK)
| Closing information | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Turnover |
9,277
|
7,328
|
3,507 |
| Financial expenses |
1,226
|
291
|
511 |
| Earnings before taxes |
-92,546
|
-124,791
|
-114,740 |
| EBITDA |
-82,873
|
-118,035
|
-105,993 |
| Total assets |
69,907
|
132,101
|
178,607 |
| Current assets |
33,145
|
88,580
|
124,391 |
| Current liabilities |
19,544
|
28,440
|
24,505 |
| Equity capital |
46,504
|
97,151
|
143,721 |
| - share capital |
7,017
|
5,634
|
3,161 |
| Employees (average) |
26
|
37
|
31 |
Financial ratios
| Fiscal year | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Solvency |
66.5%
|
73.5%
|
80.5% |
| Turnover per employee |
357
|
198
|
113 |
| Profit as a percentage of turnover |
-997.6%
|
-1702.9%
|
-3271.7% |
| Return on assets (ROA) |
-130.6%
|
-94.2%
|
-64.0% |
| Current ratio |
169.6%
|
311.5%
|
507.6% |
| Return on equity (ROE) |
-199.0%
|
-128.5%
|
-79.8% |
| Change turnover |
1,430
|
3,928
|
1,387 |
| Change turnover % |
18%
|
115%
|
65% |
| Chg. No. of employees |
-11
|
6
|
6 |
| Chg. No. of employees % |
-30%
|
19%
|
24% |
Total value of public sale
| Fiscal year | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.